| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/17/2008 | WO2008084270A1 Hepatic marker proteins for insulin resistance |
| 07/17/2008 | WO2008084044A1 Urea glucokinase activators |
| 07/17/2008 | WO2008084043A1 Urea glucokinase activators |
| 07/17/2008 | WO2008083678A2 Pharmaceutically active compounds |
| 07/17/2008 | WO2008083551A1 4-substituted oxyphenyl quinolines, intermediate compounds, preparation methods and uses thereof |
| 07/17/2008 | WO2008083543A1 Nitrogen-containing heterocyclic modified compounds and uses thereof |
| 07/17/2008 | WO2008083513A1 Black soybean hull extract and process for preparation and use thereof |
| 07/17/2008 | WO2008067219A3 Quinazolinone modulators of tgr5 |
| 07/17/2008 | WO2008050101A3 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 07/17/2008 | WO2008045564A8 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 07/17/2008 | WO2008030584A3 Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase |
| 07/17/2008 | WO2008029349A3 Muscarinic receptor antagonists |
| 07/17/2008 | WO2008023278A3 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 07/17/2008 | WO2007073177A3 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 07/17/2008 | US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation |
| 07/17/2008 | US20080171784 Stabilization of the pharmaceutical active solid substance atorvastatin (Lipitor) alone or in a mixture with other solid substances embedded in a surrounding gaseous mixturewhere a partial pressure of oxygen of at < 2 kPa is maintained; amorphous; blister-pack using an oxygen self-activating absorber |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171776 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator - activated receptor (ppar) ligands, process for their preparation and methods of use thereof |
| 07/17/2008 | US20080171775 Ramipril-amlodipine salt |
| 07/17/2008 | US20080171769 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| 07/17/2008 | US20080171761 Substituted spirochromanone derivatives |
| 07/17/2008 | US20080171730 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes and vascular and renal disorders |
| 07/17/2008 | US20080171704 Composition and method for treating diabetes |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171700 Use Of Secretagogue For The Teatment Of Ghrelin Deficiency |
| 07/17/2008 | US20080171695 Acylated with polyethylene glycol, polypropylene glycol or polybutylene glycol in combination with a fatty diacid; improved bioavailability, first pass effect, solubility at physiological pH values and prolonged pharmacokinetics |
| 07/17/2008 | US20080171694 Forming a suspension by combining an acidic solution of insulin, zinc chloride, protamine, phenol or m-cresol, glycerol as an isotonic agent, and sodium chloride with a basic solution of disodium phosphate, phenol or m-cresol, glycerol and sodium chloride; quick release as well as time-release action |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171032 Nutrient mixture comprising free radical quenchers for use in ameliorating or preventing detrimental effects of oxidative stress |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/17/2008 | DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses |
| 07/17/2008 | DE202008005023U1 Verwendung von α-Liponsäure und Coenzym Q10 zur selektiven Reduktion des visceralen Fettgewebes Use of α-lipoic acid and coenzyme Q10 for the selective reduction of visceral adipose tissue |
| 07/17/2008 | CA2809276A1 Food products comprising a slowly digestable or digestion resistant carbohydrate composition |
| 07/17/2008 | CA2675111A1 Urea glucokinase activators |
| 07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
| 07/17/2008 | CA2673654A1 5-pyridinone substituted indazoles |
| 07/17/2008 | CA2673635A1 5-furopyridinone substituted indazoles |
| 07/17/2008 | CA2672307A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/17/2008 | CA2671943A1 Compounds having both angiotensin ii receptor antagonism and ppary activating activities |
| 07/17/2008 | CA2637125A1 Food products comprising a slowly digestible or digestion resistant carbohydrate composition |
| 07/16/2008 | EP1944301A1 Novel benzoxathiin derivative |
| 07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
| 07/16/2008 | EP1944295A1 Non-racemic mixtures of (R)-N-piperidinyl-5-(4-chlorophenyl)1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide and (S)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide |
| 07/16/2008 | EP1944294A1 Gamma-polymorph of a substituted pyrazoline, its preparation and use as medicaments |
| 07/16/2008 | EP1944293A1 Alpha-Polymorph of a substituted pyrazoline, its preparation and use as medicaments |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
| 07/16/2008 | EP1944029A1 Pharmaceutical preparation having excellent photostability |
| 07/16/2008 | EP1944025A1 Stable pharmaceutical compositions of orlistat |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1943274A2 Treatment of diabetes related obesity |
| 07/16/2008 | EP1943251A2 A1 adenosine receptor agonists |
| 07/16/2008 | EP1943245A2 1,3-disubstituted indole derivatives for use as ppar modulators |
| 07/16/2008 | EP1943231A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 07/16/2008 | EP1943229A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 07/16/2008 | EP1943227A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 07/16/2008 | EP1943226A2 Phenol ethers as modulators of the opioid receptors |
| 07/16/2008 | EP1943215A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/16/2008 | EP1942911A1 Therapeutic molecules and their uses |
| 07/16/2008 | EP1942904A2 Cholesteryl ester transfer protein inhibitors |
| 07/16/2008 | EP1942898A1 Dipeptidyl peptidase inhibitors for treating diabetes |
| 07/16/2008 | EP1942897A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/16/2008 | EP1942895A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/16/2008 | EP1942747A1 Chewing gum |
| 07/16/2008 | EP1942724A1 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto |
| 07/16/2008 | EP1830840B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2008 | EP1660067B1 Methods and materials for treating conditions associated with metabolic disorders |
| 07/16/2008 | EP1583532B1 Quinoline derivatives as glucokinase ligands |
| 07/16/2008 | EP1517890B1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1386913B1 Pyrrole derivative |
| 07/16/2008 | EP1294383B1 Oral compositions comprising antimicrobial agents for the prevention of systemic diseases |
| 07/16/2008 | EP1294367B1 Oral compositions comprising host-response modulating agent |
| 07/16/2008 | EP1178789B1 Method of treating eating disorders |
| 07/16/2008 | CN101223178A Therapeutic agents |
| 07/16/2008 | CN101223163A New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 07/16/2008 | CN101223159A Pyrazole derivatives as CBI modulators |
| 07/16/2008 | CN101223158A N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 07/16/2008 | CN101223151A 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
| 07/16/2008 | CN101222950A Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 07/16/2008 | CN101222931A Cynara scolymus extracts, the use thereof and formulations containing them |
| 07/16/2008 | CN101222928A Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives |
| 07/16/2008 | CN101222919A Combination of a DPP-iv inhibitor and a cannabinoid CB1 receptor antagonist |
| 07/16/2008 | CN101220100A Separation and purification method for squash polyoses and use of obtained component |
| 07/16/2008 | CN101220098A Neutralizing antibodies against GDF-8 and uses therefor |
| 07/16/2008 | CN101220088A Amalgamation protein of human glucagons-like peptide-1and uses thereof |
| 07/16/2008 | CN101220021A 4-substituted phenoxyl quinoline compounds and midbody, production method, application thereof |
| 07/16/2008 | CN101219210A Agent kit containing oral insulin solid therapy |
| 07/16/2008 | CN101219209A Insulin-protamine zinc injection and method for preparing the same |
| 07/16/2008 | CN101219208A Medicine use of interleukin-22 |
| 07/16/2008 | CN101219199A Chinese medicine compound preparation for reducing blood fat and improving blood flowing deformation |
| 07/16/2008 | CN101219186A Weight reducing essence |
| 07/16/2008 | CN101219185A Weight reducing essence liquid |
| 07/16/2008 | CN101219175A Weight reducing essential oil |
| 07/16/2008 | CN101219165A Unfermented gel fraction from psyllium seed husks |
| 07/16/2008 | CN101219157A method for preparing product for reducing blood sugar |
| 07/16/2008 | CN101219153A Maggot tegument refuse removing anti thrombosis |
| 07/16/2008 | CN101219141A Use of berberine in treating metabolism complex |